LILLY

📅 Upcoming

🕒 Recent(90d)

News

• Lilly's triple-G drug retatrutide outshines Novo's Ozempic in diabetes
  Eli Lilly’s retatrutide, the incretin shot that has already proven its effectiveness against other assets on a cross-trial basis, has cemented its utility in a head-to-head trial, albeit in diabete…
  endpoints · 1h ago
• STAT+: Lilly says ‘triple-G’ drug beats Novo’s Ozempic in diabetes study
  Data add to expectations that the drug will be one of Lilly’s greatest growth drivers.
  stat · 1h ago
• Have you been impacted by Epic’s actions?
  STAT is looking to learn, from people with direct knowledge, how Epic's actions impact hospitals' technology choices. Share your story with us.
  stat · 3h ago
• 5 new drug launches that defied industry expectations
  A clearly superior clinical profile, reasonable pricing and easy access has helped a handful of recently approved therapies achieve impressive launches.
  biospace · 8h ago
• Big Pharma is ready to strike, with J&J most likely to buy: Leerink
  The largest pharmas have a collective $188 billion in firepower to spend on M&A transactions, with all but one signaling a desire to execute, according to a new analysis from Leerink Partners.
  biospace · 8h ago
• STAT+: Missouri AG warns Lilly to stop requiring data from hospitals seeking 340B drug discounts
  Missouri AG told Lilly to stop forcing hospitals to provide claims data to receive discounted medicines under 340B, a sign more states are pushing back against drugmakers.
  stat · 17h ago
• Lilly's ads can continue after Novo challenge, judge rules
  Novo Nordisk has suffered another setback in its uphill battle against Eli Lilly in the booming obesity drug market after a US judge rejected its attempt to block television ads that Novo alleges a…
  endpoints · 18h ago
• Court rejects Novo bid to block Lilly obesity drug ads
  Novo failed to prove that Lilly’s campaign — which featured claims of obesity drug superiority — meaningfully harmed the Danish company’s sales, a federal judge ruled.
  biopharma_dive · 20h ago
• Teva closing New Jersey manufacturing facility, laying off 61 employees
  Follow along as BioSpace tracks job cuts and restructuring initiatives.
  biospace · 21h ago
• STAT+: Nonprofit resurrects shelved gene therapy after startup shuts down
  Last year, U.K. gene therapy startup Bloomsbury Genetic Therapies announced it was shutting down after dosing just one patient. Now, a nonprofit is resurrecting its lead program:
  stat · 21h ago